Back to top
Top
U.S. flag

An official website of the United States government

Bone density evaluation for patients with prostate cancer and receiving androgen deprivation therapy

Compare Versions of: "Bone density evaluation for patients with prostate cancer and receiving androgen deprivation therapy"

The Compare function compares two years of the measure specifications found in the header of the measure's HTML. It does not include a comparison of any information in the body of the HTML, e.g., population criteria, Clinical Quality Language, or value sets.

Strikethrough text highlighted in red indicates information changed from the previous version. Text highlighted in green indicates information updated in the new eCQM version.

Compare 2024 version to

Table Options
Measure Information 2024 Performance Period
Title Bone density evaluation for patients with prostate cancer and receiving androgen deprivation therapy
CMS eCQM ID CMS645v7
CBE ID* Not Applicable
MIPS Quality ID 462
Measure Steward Oregon Urology
Description

Percentage of patients determined as having prostate cancer who are currently starting or undergoing androgen deprivation therapy (ADT), for an anticipated period of 12 months or greater and who receive an initial bone density evaluation. The bone density evaluation must be prior to the...

Show more >
Measure Scoring Proportion measure
Measure Type Process
Stratification

None

Risk Adjustment

None

Rationale

Androgen suppression as a treatment for prostate cancer can cause osteoporosis (Qaseem, 2008). Men undergoing prolonged androgen deprivation therapy (ADT) incur bone loss at a rate higher than menopausal women (Guise, 2007). In preserving bone health, the goal is to prevent or treat...

Show more >
Clinical Recommendation Statement

Bone density screening should be performed at the start of Androgen Deprivation Therapy (ADT) for prostate cancer. It should also be performed every 2 years for the patient with continued ADT or for patients with known osteoporosis. Current insurance practice is to possibly cover the...

Show more >
Improvement Notation

A higher score indicates better quality

Definition

DEXA - Dual Energy X-ray Absorptiometry - A scan that measures the bone of the spine, hip or total body and measures bone mineral density. It is considered one of the most accurate measurements.

PDXA - Peripheral Dual Energy X-ray Absorptiometry - Bone mineral density measurement of the...

Show more >
Guidance

In order to capture the practitioner's intent of androgen deprivation therapy (ADT) for a period of 12 months or greater, SNOMEDCT 456381000124102 which is Injection of leuprolide acetate for twelve month period (regime/therapy) is the correct code.

This eCQM is a patient-based measure.

Th...

Show more >
Initial Population

Male patients with a qualifying encounter in the measurement period AND with a diagnosis of prostate cancer AND with an order for ADT or an active medication of ADT with an intent for treatment greater than or equal to 12 months during the measurement period

Denominator

Equals Initial Population

Denominator Exclusions

None

Numerator

Patients with a bone density evaluation within the two years prior to the start of or less than three months after the start of ADT treatment

Numerator Exclusions

Not Applicable

Denominator Exceptions

Patient refused the bone density evaluation at the time ordered or did not have it performed within 3 months after the start of ADT

Telehealth Eligible Yes
Next Version
Previous Version

Header

  • Updated language in the description to use 'percentage of patients' for consistency with measure intent.

    Measure Section: Description

    Source of Change: Measure Lead

  • Updated copyright.

    Measure Section: Copyright

    Source of Change: Annual Update

  • Updated grammar, wording, and/or formatting to improve readability and consistency.

    Measure Section: Rationale

    Source of Change: Annual Update

  • Updated references.

    Measure Section: Reference

    Source of Change: Measure Lead

Logic

  • Updated timing of ADT order or active start date to anchor all data to the measurement period or the prior year.

    Measure Section: Initial Population

    Source of Change: Measure Lead

  • Updated the timing precision in definitions by adding 'on or' and 'day of' to align with the measure intent.

    Measure Section: Definitions

    Source of Change: Measure Lead

  • Updated timing of ADT order or active start date to anchor all data to the measurement period or the prior year.

    Measure Section: Definitions

    Source of Change: Measure Lead

Value Set

The VSAC is the source of truth for the value set content, please visit the VSAC for downloads of current value sets.

  • Value set Patient Declined (2.16.840.1.113883.3.526.3.1582): Added 1 SNOMED CT code (895451009) based on terminology update. Deleted 3 SNOMED CT codes (183944003, 413310006, 413312003) based on terminology update.

    Measure Section: Terminology

    Source of Change: Annual Update

  • Value set Payer (2.16.840.1.114222.4.11.3591): Added 5 SOP codes (1111, 1112, 142, 344, 141) based on review by technical experts, SMEs, and/or public feedback.

    Measure Section: Terminology

    Source of Change: Measure Lead

Last Updated: Sep 24, 2024